The latest immunotherapy news and developments
New approach in targeted therapies for solid tumour cancers
By silencing the molecular pathway that prevents macrophages from attacking our own cells, Penn Engineers…
Browsing: Immunotherapy
New cancer immunotherapy approach improves efficacy and side effects in mice
Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune…
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer
A team led by the National Cancer Centre Singapore (NCCS) with members from Singapore General…
Some intestinal T cells can hinder cancer immunotherapy, while others can enhance it
Two new studies in Science and Science Immunology spotlight a group of intestinal T cells with α4β7 integrin receptors…
ASCO 2023: Personalised vaccines may revolutionise cancer treatment
Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives…
Untapping the full potential of immunotherapies for more people with cancer
Immunotherapy works by sparking the body’s own immune system into action against tumours. It has…
ASCO 2023: Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Cyteph secures vital funding for brain cancer immunotherapy phase 1 clinical trial
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute, has been awarded a…
Researchers identify potential new strategy to prevent side effects from immunotherapy
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that IL-21, a soluble…
Preclinical candidate to target ENPP1 for cancer immunotherapy and the treatment of rare disease using generative AI
An AI-driven drug discovery company has announced a potentially best-in-class preclinical candidate targeting ENPP1 for cancer immunotherapy…